Table 1 The main characteristics of included studies in this meta-analysis
First author | Region | Country | Race | Method | Sample | Control | Case | Control | Stage 1-2 | Stage 3-4 | Serous | Non-serous |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
M/N | M/N | M/N | M/N | M/N | M/N | |||||||
Rathi 2002 [35] | Promoter | USA | Caucasians | MSP | Tissue | NMT | 14/49 | 2/39 | - | - | - | - |
Makarla 2005 [21] | Promoter | USA | Caucasians | MSP | Tissue | NMT | 6/23 | 4/39 | - | - | 2/9 | 3/13 |
Makarla 2005 [21] | Promoter | USA | Caucasians | MSP | Tissue | LMP | 6/23 | 4/23 | - | - | - | - |
Yuecheng 2006 [26] | Promoter | China | Asians | MSP | Tissue | NMT | 34/80 | 0/34 | - | - | - | - |
Shen 2007 [23] | Promoter | China | Asians | MSP | Tissue | NMT | 18/63 | 1/30 | 2/22 | 16/41 | 9/34 | 9/29 |
Montavon 2012 [34] | Promoter | Australia | Caucasians | MSHSP | Tissue | NMT | 17/78 | 1/5 | - | - | - | - |
Bhagat 2013 [20] | Promoter | India | Asians | MSP | Tissue | NM | 31/86 | 2/34 | 8/23 | 23/63 | 17/44 | 7/25 |
Bhagat 2013 [20] | Promoter | India | Asians | MSP | Tissue | LMP | 31/86 | 2/14 | - | - | - | - |
Wu 2014 [25] | Promoter | China | Asians | MSP | Tissue | NMT | 32/50 | - | 7/12 | 25/38 | 25/35 | 7/15 |
Moselhy 2015 [22] | Promoter | Saudi Arabia | Asians | MSP | Tissue | NMT | 12/18 | 8/32 | - | - | - | - |
Sun and Zhang 2015 [24] | Promoter | China | Asians | MSP | Tissue | NMT | 15/38 | 1/42 | - | - | - | - |